De novo Thrombotic Microangiopathy Induced by Cytomegalovirus Infection Leading to Renal Allograft Loss

被引:22
作者
De Keyzer, Kristel [1 ]
Van Laecke, Steven [1 ]
Peeters, Patrick [1 ]
Vanholder, Raymond [1 ]
机构
[1] Ghent Univ Hosp, Div Renal, BE-9000 Ghent, Belgium
关键词
Cytomegalovirus infection; Hemolytic-uremic syndrome; Kidney transplantation; Thrombotic microangiopathy; HEMOLYTIC-UREMIC SYNDROME; KIDNEY-TRANSPLANTATION; THROMBOCYTOPENIC PURPURA; MUTATION; THERAPY;
D O I
10.1159/000321328
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
After kidney transplantation, thrombotic microangiopathy (TMA) can occur de novo or as recurrent disease. Risk factors for de novo posttransplant TMA include ischemia-reperfusion injury, immunosuppressive drugs, viral infections, acute humoral rejection, and complement gene abnormalities. Cytomegalovirus infection as a trigger for posttransplant TMA in kidney transplant recipients has only been reported in 7 cases, all of them between 4 weeks and 8 years after transplantation. We describe a new case of de novo TMA in association with cytomegalovirus infection 25 years after kidney transplantation. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:491 / 496
页数:6
相关论文
共 17 条
[1]   Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome [J].
Ariceta, Gema ;
Besbas, Nesrin ;
Johnson, Sally ;
Karpman, Diana ;
Landau, Daniel ;
Licht, Christoph ;
Loirat, Chantal ;
Pecoraro, Carmine ;
Taylor, C. Mark ;
Van de Kar, Nicole ;
VandeWalle, Johan ;
Zimmerhackl, Lothar B. .
PEDIATRIC NEPHROLOGY, 2009, 24 (04) :687-696
[2]   A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders [J].
Besbas, N. ;
Karpman, D. ;
Landau, D. ;
Loirat, C. ;
Proesmans, W. ;
Remuzzi, G. ;
Rizzoni, G. ;
Taylor, C. M. ;
Van de Kar, N. ;
Zimmerhackl, L. B. .
KIDNEY INTERNATIONAL, 2006, 70 (03) :423-431
[3]   Immunobiology of Human Cytomegalovirus: from Bench to Bedside [J].
Crough, Tania ;
Khanna, Rajiv .
CLINICAL MICROBIOLOGY REVIEWS, 2009, 22 (01) :76-+
[4]   TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY - THE ROLE OF IGG ADMINISTRATION AS INITIAL THERAPY [J].
HOCHSTETLER, LA ;
FLANIGAN, MJ ;
LAGER, DJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (03) :444-450
[5]   Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient - A new treatment strategy [J].
Jeejeebhoy, FM ;
Zaltzman, JS .
TRANSPLANTATION, 1998, 65 (12) :1645-1648
[6]   Outcome of plasma exchange therapy in thrombotic microangiopathy after renal transplantation [J].
Karthikeyan, V ;
Parasuraman, R ;
Shah, V ;
Vera, E ;
Venkat, KK .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (10) :1289-1294
[7]   International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation [J].
Kotton, Camille N. ;
Kumar, Deepali ;
Caliendo, Angela M. ;
Asberg, Anders ;
Chou, Sunwen ;
Snydman, David R. ;
Allen, Upton ;
Humar, Atul .
TRANSPLANTATION, 2010, 89 (07) :779-795
[8]   Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation [J].
Le Quintrec, M. ;
Lionet, A. ;
Kamar, N. ;
Karras, A. ;
Barbier, S. ;
Buchler, M. ;
Fakhouri, F. ;
Provost, F. ;
Fridiman, W. H. ;
Thervet, E. ;
Legendre, C. ;
Zuber, J. ;
Fremeaux-Bacchi, V. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (08) :1694-1701
[9]  
NOEL C, 1992, ANN MED INTERNE, V143, P33
[10]   Thrombotic Microangiopathy After Kidney Transplantation [J].
Noris, M. ;
Remuzzi, G. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (07) :1517-1523